
1. General Information
Rifagut 550 mg Tablet contains rifaximin 550 mg, a rifamycin-class antibacterial medicine that primarily acts inside the gastrointestinal tract. Rifagut is marketed in India by Sun Pharmaceutical Industries Ltd.
Rifaximin has approved clinical uses that include reducing the recurrence of overt hepatic encephalopathy in adults and, depending on the approved indication and country, treatment of certain diarrheal conditions and IBS with diarrhea.
This is a prescription medicine and should be used under the supervision of a qualified healthcare professional.
2. Product Information
Brand: Rifagut 550 mg
Active ingredient: Rifaximin
Strength: 550 mg
Dosage form: Oral tablet
Drug class: Rifamycin antibacterial
Route: Oral
Typical storage: Store below 30°C, according to listed product information.
Availability: Prescription medicine
Exporter: Phoenix Exim, Nagpur, India
Rifaximin has limited systemic absorption after oral administration, allowing it to act predominantly within the intestinal tract.
3. Uses of Rifagut 550 mg
Rifagut may be prescribed for conditions where rifaximin is appropriate, including:
Reducing the risk of recurrence of overt hepatic encephalopathy (HE) in adults.
Certain bacterial intestinal infections or infectious diarrhea, where clinically appropriate.
Irritable bowel syndrome with diarrhea (IBS-D) in adults in countries where this indication is approved.
The appropriate indication depends on the patient's condition, local regulatory approval, and the doctor's prescription.
4. Benefits of This Medicine
When appropriately prescribed, Rifagut 550 mg may:
Help reduce the intestinal bacterial activity associated with hepatic encephalopathy.
Reduce the risk of recurrent episodes of overt hepatic encephalopathy in appropriate adult patients.
Help manage certain bacterial intestinal conditions when rifaximin is indicated.
Act mainly in the gastrointestinal tract because comparatively little rifaximin reaches the systemic circulation.
5. Side Effects of Rifagut 550 mg
Like other medicines, Rifagut can cause side effects. These may vary according to the condition being treated.
Possible adverse effects include:
Headache
Nausea
Dizziness
Constipation
Fatigue
Abdominal discomfort
Increased liver enzymes
Itching
Swelling or peripheral edema
Serious reactions are uncommon, but allergic reactions and antibiotic-associated diarrhea, including C. difficile-associated diarrhea, require medical attention.
6. Common Side Effects
Some commonly reported effects include:
Headache
Nausea
Dizziness
Constipation
Fatigue
Peripheral edema
Itching
Insomnia
The exact frequency can vary depending on the indication and patient population.
Seek prompt medical advice if severe diarrhea, significant allergic symptoms, or other serious or persistent reactions occur.
7. How to Use Rifagut 550 mg
Take Rifagut exactly as prescribed by your doctor.
Swallow the tablet whole with water.
Do not crush, chew, or break the tablet unless specifically instructed.
It may generally be taken with or without food.
Take doses at approximately the same time each day.
Complete the prescribed treatment course unless your healthcare professional tells you otherwise.
For hepatic encephalopathy, the FDA-approved rifaximin regimen is 550 mg twice daily. For IBS-D, the approved regimen is 550 mg three times daily for 14 days; dosing for other conditions can differ. Do not self-select a dosage.
8. How Rifagut 550 mg Works
Rifagut contains rifaximin, which acts against susceptible bacteria in the gastrointestinal tract. It inhibits bacterial RNA synthesis, interfering with the bacteria's ability to produce essential proteins and reproduce.
In hepatic encephalopathy, reducing intestinal bacteria involved in the production of ammonia and other nitrogenous substances can help reduce the risk of recurrent overt episodes.
9. Safety Advice
Use only under medical supervision.
Do not use Rifagut if you have a known allergy to rifaximin, rifamycin antibiotics, or any component of the product.
Inform your doctor if you have severe liver disease. Rifaximin exposure can be substantially increased in patients with hepatic impairment, particularly severe impairment.
Tell your doctor about all medicines you take, particularly warfarin and medicines that affect P-glycoprotein such as cyclosporine.
Contact a healthcare professional if diarrhea becomes severe, bloody, is accompanied by fever, or develops during or after antibiotic treatment.
Discuss use during pregnancy or breastfeeding with your doctor before taking the medicine.
Keep the medicine out of reach of children.
Store according to the product label and protect the tablets from unsuitable storage conditions.
10. Frequently Asked Questions (FAQs)
Q1. What is Rifagut 550 mg used for?
Rifagut contains rifaximin and may be prescribed for reducing recurrence of overt hepatic encephalopathy in adults and for certain gastrointestinal conditions depending on the approved indication.
Q2. Is Rifagut 550 mg an antibiotic?
Yes. Rifaximin is a rifamycin-class antibacterial medicine.
Q3. Can Rifagut 550 mg be taken with food?
Yes. Rifaximin 550 mg can generally be taken with or without food.
Q4. Can I stop Rifagut when I feel better?
Do not stop or change treatment without consulting your doctor. Follow the prescribed duration.
Q5. Can Rifagut treat every type of diarrhea?
No. Rifaximin is not appropriate for every cause of diarrhea. For example, the FDA label specifies limitations for travelers' diarrhea associated with fever or blood in the stool and diarrhea caused by pathogens other than susceptible E. coli.
Q6. Is Rifagut 550 mg safe for people with liver disease?
It may be prescribed for certain liver-related conditions, but patients with severe hepatic impairment require particular caution because rifaximin exposure can increase substantially.
Q7. What should I do if I develop severe diarrhea while taking Rifagut?
Contact your healthcare professional promptly because antibiotic-associated diarrhea, including C. difficile-associated diarrhea, can occur.
Q8. Is Rifagut 550 mg available as a prescription medicine?
Yes. Rifagut 550 mg is listed as a prescription medicine in India.
11. Substitutes for Rifagut 550 mg
Potential substitutes are products containing the same active ingredient, rifaximin 550 mg, such as other locally approved rifaximin brands. Examples listed in Indian medicine databases include Retragut 550 mg and Rifguard 550 mg.
A substitute should not be selected solely by brand name. The strength, formulation, approved indication, manufacturer, country-specific regulatory status, and doctor's prescription should be checked before substitution.
12. SEO Keywords
Rifagut 550 mg tablets exporter from India
Rifagut 550 mg tablets supplier
Rifagut 550 mg pharmaceutical exporter
Rifagut 550 mg medicine exporter from Nagpur
Rifaximin 550 mg tablets exporter India
Rifaximin 550 mg supplier from India
Rifaximin 550 mg pharmaceutical supplier
Rifagut 550 mg tablets international supplier
Rifagut 550 mg tablets wholesale supplier
Rifagut 550 mg tablets export from India
Rifagut 550 mg tablets supplier USA
Rifagut 550 mg tablets supplier UK
Rifagut 550 mg tablets supplier Australia
Rifagut 550 mg tablets supplier Canada
Rifagut 550 mg tablets supplier Singapore
Rifagut 550 mg tablets supplier South Korea
Rifagut 550 mg tablets supplier UAE
Rifaximin 550 mg exporter to USA
Rifaximin 550 mg exporter to UK
Rifaximin 550 mg exporter to Australia
Rifaximin 550 mg exporter to Canada
Rifaximin 550 mg exporter to Singapore
Rifaximin 550 mg exporter to South Korea
Rifaximin 550 mg exporter to UAE
Trusted pharmaceutical exporter from Nagpur India
Indian pharmaceutical medicine exporter
Global rifaximin medicine supplier
Hepatic encephalopathy medicine supplier
Rifaximin tablets for hepatic encephalopathy
Rifagut 550 mg international pharmaceutical supplier
Keywords







